Your browser doesn't support javascript.
loading
The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region.
Luce, Richard; Masresha, Balcha G; Katsande, Regis; Fall, Amadou; Shibeshi, Messeret Eshetu.
Afiliación
  • Luce R; WHO Inter-country Support Team for Central Africa, Libreville, Gabon.
  • Masresha BG; WHO Regional Office for Africa, Brazzaville, Congo.
  • Katsande R; WHO Regional Office for Africa, Brazzaville, Congo.
  • Fall A; WHO Inter-country Support Team for Western Africa, Ouagadougou, Burkina Faso.
  • Shibeshi ME; WHO Inter-country Support Team for East and Southern Africa, Harare, Zimbabwe.
J Immunol Sci ; Suppl(16): 108-112, 2018 Jul 28.
Article en En | MEDLINE | ID: mdl-30957104
ABSTRACT
The World Health Organization (WHO) recommends that countries introduce rubella containing vaccines (RCVs) to reduce rubella circulation and the occurrence of congenital rubella syndrome (CRS). As of June 2017, a total of 18 countries have already introduced or are in the process of introducing RCV in routine child vaccination programs. RCV introduction during 2013 - 2014 in five countries in the Region resulted in a reduction of rubella incidence of 48% to 96% in the post-introduction period as compared to the average incidence in the years before introduction. These results suggest that initial mass vaccination campaigns and introduction of RCVs in routine immunization programs result in significant reduction in rubella incidence and a reduced potential for the occurrence of CRS.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Immunol Sci Año: 2018 Tipo del documento: Article País de afiliación: Gabón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Immunol Sci Año: 2018 Tipo del documento: Article País de afiliación: Gabón